Literature DB >> 33097483

CD31+ Extracellular Vesicles From Patients With Type 2 Diabetes Shuttle a miRNA Signature Associated With Cardiovascular Complications.

Francesco Prattichizzo1, Valeria De Nigris2, Jacopo Sabbatinelli3, Angelica Giuliani4, Carlos Castaño2,5, Marcelina Párrizas2,5, Isabel Crespo6, Annalisa Grimaldi7, Nicolò Baranzini7, Rosangela Spiga8, Elettra Mancuso8, Maria Rita Rippo4, Antonio Domenico Procopio4,9, Anna Novials2,5, Anna Rita Bonfigli10, Silvia Garavelli11, Lucia La Sala12, Giuseppe Matarese11,13, Paola de Candia12, Fabiola Olivieri4,9, Antonio Ceriello12.   

Abstract

Innovative biomarkers are needed to improve the management of patients with type 2 diabetes mellitus (T2DM). Blood circulating miRNAs have been proposed as a potential tool to detect T2DM complications, but the lack of tissue specificity, among other reasons, has hampered their translation to clinical settings. Extracellular vesicle (EV)-shuttled miRNAs have been proposed as an alternative approach. Here, we adapted an immunomagnetic bead-based method to isolate plasma CD31+ EVs to harvest vesicles deriving from tissues relevant for T2DM complications. Surface marker characterization showed that CD31+ EVs were also positive for a range of markers typical of both platelets and activated endothelial cells. After characterization, we quantified 11 candidate miRNAs associated with vascular performance and shuttled by CD31+ EVs in a large (n = 218) cross-sectional cohort of patients categorized as having T2DM without complications, having T2DM with complications, and control subjects. We found that 10 of the tested miRNAs are affected by T2DM, while the signature composed by miR-146a, -320a, -422a, and -451a efficiently identified T2DM patients with complications. Furthermore, another CD31+ EV-shuttled miRNA signature, i.e., miR-155, -320a, -342-3p, -376, and -422a, detected T2DM patients with a previous major adverse cardiovascular event. Many of these miRNAs significantly correlate with clinical variables held to play a key role in the development of complications. In addition, we show that CD31+ EVs from patients with T2DM are able to promote the expression of selected inflammatory mRNAs, i.e., CCL2, IL-1α, and TNFα, when administered to endothelial cells in vitro. Overall, these data suggest that the miRNA cargo of plasma CD31+ EVs is largely affected by T2DM and related complications, encouraging further research to explore the diagnostic potential and the functional role of these alterations.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 33097483     DOI: 10.2337/db20-0199

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  The Role of Extracellular Non-coding RNAs in Atherosclerosis.

Authors:  Yuting Cui; Yating Zhou; Ni Gan; Qiong Xiang; Mengdie Xia; Wei Liao; Xi-Long Zheng; Juan Peng; Zhihan Tang
Journal:  J Cardiovasc Transl Res       Date:  2022-03-01       Impact factor: 3.216

2.  Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin.

Authors:  Antonio Ceriello; Francesco Prattichizzo; Rosalba La Grotta; Paola de Candia; Fabiola Olivieri; Giulia Matacchione; Angelica Giuliani; Maria Rita Rippo; Elena Tagliabue; Monica Mancino; Francesca Rispoli; Sabina Ferroni; Cesare Celeste Berra
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.207

3.  Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology.

Authors:  Yury O Nunez Lopez; Anton Iliuk; Alejandra M Petrilli; Carley Glass; Anna Casu; Richard E Pratley
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

4.  Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis.

Authors:  Francesco Prattichizzo; Paola de Candia; Antonio Nicolucci; Antonio Ceriello
Journal:  Diabetes Metab Res Rev       Date:  2021-05-28       Impact factor: 8.128

5.  Fluorescence-Based Nanoparticle Tracking Analysis and Flow Cytometry for Characterization of Endothelial Extracellular Vesicle Release.

Authors:  Johannes Oesterreicher; Marianne Pultar; Jaana Schneider; Severin Mühleder; Johannes Zipperle; Johannes Grillari; Wolfgang Holnthoner
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

Review 6.  Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications.

Authors:  Jing Liu; Yanyan Zhang; Yan Tian; Wei Huang; Nanwei Tong; Xianghui Fu
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 7.  To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Maurice B Fluitt; Neal Mohit; Kanwal K Gambhir; Gail Nunlee-Bland
Journal:  J Diabetes Res       Date:  2022-02-21       Impact factor: 4.011

8.  MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS.

Authors:  Marilena Durazzo; Gabriella Gruden; Federica Barutta; Beatrice Corbetta; Stefania Bellini; Simonetta Guarrera; Giuseppe Matullo; Michela Scandella; Casper Schalkwijk; Coen D Stehouwer; Nish Chaturvedi; Sabita S Soedamah-Muthu
Journal:  J Transl Med       Date:  2021-11-25       Impact factor: 5.531

Review 9.  Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart's Vulnerability to Ischemia-Reperfusion Injury.

Authors:  Miłosz Majka; Marcin Kleibert; Małgorzata Wojciechowska
Journal:  Cells       Date:  2021-11-27       Impact factor: 6.600

Review 10.  Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms.

Authors:  Celestino Sardu; Raffaele Marfella; Francesco Prattichizzo; Rosalba La Grotta; Giuseppe Paolisso; Antonio Ceriello
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.